Ionis Pharma (IONS) Tops Q2 EPS by 5c

Ionis Pharma (NASDAQ: IONS) reported Q2 EPS of ($0.47), $0.05 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $38.52 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
• Morgan Stanley Resumes Global Payments (GPN) at Equalweight